MEDIFAST (MED)
(Delayed Data from NYSE)
$33.71 USD
+0.21 (0.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $33.71 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth F Momentum B VGM
Income Statements
Fiscal Year end for MEDIFAST INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,072 | 1,599 | 1,526 | 935 | 714 |
Cost Of Goods | 296 | 458 | 398 | 237 | 177 |
Gross Profit | 776 | 1,140 | 1,128 | 698 | 537 |
Selling & Adminstrative & Depr. & Amort Expenses | 649 | 956 | 911 | 564 | 446 |
Income After Depreciation & Amortization | 126 | 185 | 216 | 134 | 91 |
Non-Operating Income | 2 | 0 | 0 | 0 | 1 |
Interest Expense | 0 | 1 | 0 | 0 | 0 |
Pretax Income | 129 | 184 | 216 | 134 | 92 |
Income Taxes | 29 | 40 | 52 | 31 | 14 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 99 | 144 | 164 | 103 | 78 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 99 | 144 | 164 | 103 | 78 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 139 | 196 | 223 | 142 | 96 |
Depreciation & Amortization (Cash Flow) | 13 | 11 | 7 | 8 | 5 |
Income After Depreciation & Amortization | 126 | 185 | 216 | 134 | 91 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.92 | 11.28 | 11.81 | 11.85 | 12.12 |
Diluted EPS Before Non-Recurring Items | 9.64 | 14.50 | 13.89 | 9.14 | 5.96 |
Diluted Net EPS (GAAP) | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 |
Fiscal Year end for MEDIFAST INC falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 191.01 | 235.87 | 296.19 | 348.98 |
Cost Of Goods | NA | 49.65 | 58.49 | 85.47 | 102.59 |
Gross Profit | NA | 141.37 | 177.38 | 210.72 | 246.39 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 132.69 | 151.87 | 172.01 | 192.88 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.68 | 25.51 | 38.71 | 53.51 |
Non-Operating Income | NA | 0.95 | 1.04 | 0.41 | 0.00 |
Interest Expense | NA | -0.18 | 0.00 | 0.00 | 0.18 |
Pretax Income | NA | 9.80 | 26.55 | 39.12 | 53.33 |
Income Taxes | NA | 3.77 | 3.42 | 8.84 | 13.36 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 6.04 | 23.13 | 30.28 | 39.97 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 6.04 | 23.13 | 30.28 | 39.97 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 10.94 | 10.93 | 10.92 | 10.90 |
Diluted EPS Before Non-Recurring Items | NA | 1.09 | 2.12 | 2.77 | 3.67 |
Diluted Net EPS (GAAP) | NA | 0.54 | 2.12 | 2.77 | 3.67 |